Stay updated on Nivolumab vs Docetaxel in Lung Cancer Clinical Trial

Sign up to get notified when there's something new on the Nivolumab vs Docetaxel in Lung Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab vs Docetaxel in Lung Cancer Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    Revision: v3.4.2 appears to be a minor software update and does not show changes to study content, eligibility criteria, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-13T12:33:07.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    Revision updated from v3.4.0 to v3.4.1. No visible changes to study content, layout, or navigation are evident on the page.
    Difference
    0.0%
    Check dated 2026-02-05T13:37:25.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    Added 'Show glossary' and updated QC-related metadata to 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and Revision: v3.4.0. Removed the previous variants 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and Revision: v3.3.4.
    Difference
    0.1%
    Check dated 2026-01-29T06:36:41.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.3.4, replacing the prior Revision: v3.3.3.
    Difference
    0.0%
    Check dated 2026-01-15T02:24:34.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    The Locations section was updated with many new sites across the United States and internationally. Several previously listed sites were removed.
    Difference
    2%
    Check dated 2025-12-23T10:10:33.000Z thumbnail image
  7. Check
    92 days ago
    Change Detected
    Summary
    Publications section wording updated to indicate that PubMed publications are auto-filled from PubMed and may not all pertain to the study, with the revision tag updated to v3.3.2. The prior wording about PubMed sourcing and revision v3.2.0 has been replaced.
    Difference
    0.1%
    Check dated 2025-11-24T17:05:53.000Z thumbnail image

Stay in the know with updates to Nivolumab vs Docetaxel in Lung Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab vs Docetaxel in Lung Cancer Clinical Trial page.